{
    "name": "hematopoietic progenitor cells, cord blood",
    "comment": "Rx",
    "other_names": [
        "HemaCord"
    ],
    "classes": [
        "Blood Components"
    ],
    "source": "https://reference.medscape.com/drug/hemacord-hematopoietic-progenitor-cells-cord-blood-999702",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Unknown whether distributed in breast milk; caution advised"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Unknown whether distributed in breast milk; caution advised"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Fatal infusion reactions ",
                    "description": [
                        "Administration can result in serious, including fatal, infusion reactions",
                        "Monitor patients and discontinue infusion for severe reactions",
                        "Contraindicated with known allergy to dimethyl sulfoxide (DMSO), Dextran 40 or human serum albumin"
                    ]
                },
                {
                    "type": "Graft vs host disease (GVHD) ",
                    "description": [
                        "GVHD is expected after administration, and may be fatal",
                        "Administration of immunosuppressive therapy may decrease the risk of GVHD"
                    ]
                },
                {
                    "type": "Engraftment syndrome ",
                    "description": [
                        "Engraftment syndrome may progress to multiorgan failure and death",
                        "Treat promptly with corticosteroids"
                    ]
                },
                {
                    "type": "Graft failure ",
                    "description": [
                        "Graft failure may be fatal",
                        "Monitor for laboratory evidence of hematopoietic recovery",
                        "Prior to choosing a specific unit of HPC-C, consider testing for HLA antibodies to identify patients who are alloimmunized"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Hypertension",
            "percent": "48"
        },
        {
            "name": "all grades",
            "percent": "2-4"
        },
        {
            "name": "Acute GVHD",
            "percent": "43"
        },
        {
            "name": "grades",
            "percent": "3-4"
        },
        {
            "name": "grades",
            "percent": "20"
        },
        {
            "name": "Day",
            "percent": "100"
        },
        {
            "name": "mortality from all causes",
            "percent": "25"
        },
        {
            "name": "Infusion reaction",
            "percent": "18"
        },
        {
            "name": "Engraftment syndrome",
            "percent": "15"
        },
        {
            "name": "Primary graft failure",
            "percent": "15"
        },
        {
            "name": "Vomiting",
            "percent": "14.5"
        },
        {
            "name": "Nausea",
            "percent": "12.7"
        },
        {
            "name": "Sinus bradycardia",
            "percent": "10.4"
        },
        {
            "name": "Allergy",
            "percent": "3.4"
        },
        {
            "name": "Hypotension",
            "percent": "2.5"
        },
        {
            "name": "Hemoglobinuria",
            "percent": "2.1"
        },
        {
            "name": "Hypoxia",
            "percent": "2"
        }
    ]
}